Suppr超能文献

复发性基底动脉血栓形成中静脉溶栓的安全给药

Safe Readministration of Intravenous Thrombolysis in Recurrent Basilar Thrombosis.

作者信息

Khan Alina, Itrat Ahmed

机构信息

North East Ohio Medical University, Rootstown, Ohio.

North East Ohio Medical University, Rootstown, Ohio; Cleveland Clinic Akron General Medical Center, Akron, Ohio.

出版信息

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):e48-e49. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.066. Epub 2017 Oct 31.

Abstract

We report a patient who had recurrence of stroke in the basilar artery territory because of repeat thrombosis, and was administered intravenous recombinant tissue plasminogen activator (IV-rtPA) twice within a span of 3 weeks without any adverse events, with radiological evidence of successful thrombolysis. Because of minor and improving stroke symptoms with IV-rtPA, endovascular therapy was not performed and there was radiological evidence of recanalization with IV-rtPA alone. This report adds to the very limited literature on the topic demonstrating safe and successful use of repeat IV thrombolysis following a previous recent stroke.

摘要

我们报告了一名患者,其基底动脉区域因再次血栓形成而发生中风复发,并在3周内两次接受静脉注射重组组织型纤溶酶原激活剂(IV-rtPA)治疗,未出现任何不良事件,且有放射学证据表明溶栓成功。由于使用IV-rtPA后中风症状轻微且有所改善,因此未进行血管内治疗,且仅有IV-rtPA治疗实现再通的放射学证据。本报告补充了关于该主题的非常有限的文献,证明了近期中风后重复静脉溶栓的安全和成功使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验